Related Experiment Video
Updated: Jun 20, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Overexpression effects of 4.1B protein on epilepsy and excitatory synaptic transmission in mice
Xueying Zhou1, Xiangqing Xu2, Wei Jiang3
1First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China; Rehabilitation Center, Qilu Hospital of Shandong University, No. 107, Wenhua Xilu, Jinan 250012, Shandong, China.
Abstract:
Protein 4.1B, part of the evolutionarily conserved protein 4.1 family known for its role as cytoskeletal adaptors, is involved in the localization of NMDA receptors. However, its significance in epilepsy is not well understood. Considering the crucial role of the imbalance between synaptic excitation and inhibition in the development of epilepsy, we proposed that 4.1B might influence the progression of chronic epilepsy by affecting synaptic transmission. Our findings indicated a marked decrease in 4.1B protein levels in the hippocampus and temporal cortex of mice with chronic epilepsy. Immunohistochemical studies showed that 4.1B is mainly found in neurons. Increasing the expression of 4.1B notably lowered the frequency of spontaneous seizures during the chronic phase, and electrophysiological assessments revealed a significant decrease in the amplitude of miniature excitatory postsynaptic currents (mEPSCs). Overall, these results imply that 4.1B plays a role in the development of chronic epilepsy by altering excitatory synaptic transmission and could serve as a potential therapeutic target for epilepsy.
More Related Videos
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
07:01Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...